Focus on decentralizing clinical trials has taken a massive leap over the year of the pandemic, as COVID-19 forced an accelerated use of telemedicine, home health options, and digital apps to keep studies running. How has the industry adapted, and what does the future hold?
In this video, Scott Scarola, VP, Decentralized Clinical Solutions Operations, sat down with PharmaVOICE editor Taren Grom to discuss the trend of DCT and the impact of COVID-19 on the industry’s approach to clinical trials overall.
View the video on the PharmaVOICE website.
